Accardo, Antonella
Mannucci, Silvia
Nicolato, Elena
Vurro, Federica
Diaferia, Carlo
Bontempi, Pietro
Marzola, Pasquina
Morelli, Giancarlo
Article History
First Online: 19 December 2018
Compliance with ethical standards
:
: A. Accardo and G. Morelli participate in a spin-off company (Invectors, srl) devoted to the development of targeted liposomal compounds for cancer therapy. The other authors report no conflicts of interest in this work.